Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months

Centre Hospitalier Universitaire de Saint Etienne

Status: Enrolling

Conditions: Endophthalmitis

Treatments: Other: Analysis of retinograms; Other: Analysis of optical coherence tomography (OCT) images; Other: Intraocular pressure analysis; Other: Visual acuity analysis

Study type: Observational

Funder types: Other

Identifiers

NCT06268561

IRBN852023/CHUSTE

Details and patient eligibility

About

OZURDEX endophthalmitis is a rare and potentially very serious pathology. Different treatments can be carried out early and change the functional prognosis of the patient.

Enrollment: 8 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who had endophtalmitis following an OZURDEX implant injection within 2 months

Exclusion criteria

• Intra oculaire procedure in the interval between the injection of OZURDEX and endophtalmitis

Trial design

8 participants in 1 patient group

OZURDEX patients

Description:

Patients treated by Dr Garcin and Pr Thuret CHU of Saint Etienne in the context of post-OZURDEX endophthalmitis

Treatment:

Other: Analysis of optical coherence tomography (OCT) images

Other: Analysis of retinograms

Other: Visual acuity analysis

Other: Intraocular pressure analysis